StudyFinder
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study
Recruiting
This is a double-blind randomized placebo-controlled clinical trial examining choline supplementation in 2-5 year old children with Fetal Alcohol Spectrum Disorders. Outcome measures are neurocognitive tests of memory, attention, and behavior.
Male or Female
Up to 18 years old
Inclusion Criteria:
• ages 2.5 years to 5 years old (<6 years of age)
• prenatal alcohol exposure
Exclusion Criteria:
• history of a neurological condition (epilepsy, traumatic brain injury)
• history of a medical condition known to affect brain function
• other neurodevelopmental disorder (autism, Down syndrome)
• history of very low birthweight (<1500 grams)
Mental Health & Addiction
Fetal Alcohol Spectrum Disorders
Mary Anthony - antho248@umn.edu
Jeffrey Wozniak
Phase 2
SITE00000121
See this study on ClinicalTrials.gov